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G E N E T I C S
R-loops trigger the release of cytoplasmic ssDNAs 
leading to chronic inflammation upon DNA damage
Ourania Chatzidoukaki1,2†, Kalliopi Stratigi1†, Evi Goulielmaki1, George Niotis1,3, 
Alexia Akalestou-Clocher1,3, Katerina Gkirtzimanaki1, Alexandros Zafeiropoulos2, 
Janine Altmüller4, Pantelis Topalis1, George A. Garinis1,3*
How DNA damage leads to chronic inflammation and tissue degeneration with aging remains to be fully resolved. 
Here, we show that DNA damage leads to cellular senescence, fibrosis, loss-of-tissue architecture, and chronic 
pancreatitis in mice with an inborn defect in the excision repair cross complementation group 1 (Ercc1) gene. We 
find that DNA damage-driven R-loops causally contribute to the active release and buildup of single-stranded 
DNAs (ssDNAs) in the cytoplasm of cells triggering a viral-like immune response in progeroid and naturally aged 
pancreata. To reduce the proinflammatory load, we developed an extracellular vesicle (EV)-based strategy to de-
liver recombinant S1 or ribonuclease H nucleases in inflamed Ercc1−/− pancreatic cells. Treatment of Ercc1−/− ani-
mals with the EV-delivered nuclease cargo eliminates DNA damage-induced R-loops and cytoplasmic ssDNAs 
alleviating chronic inflammation. Thus, DNA damage-driven ssDNAs causally contribute to tissue degeneration, 
Ercc1−/− paving the way for novel rationalized intervention strategies against age-related chronic inflammation.
INTRODUCTION
The great majority of premature aging-like (progeroid) syndromes 
are associated with inborn defects in genome maintenance, sup-
porting the notion that DNA damage drives aging and causally con-
tributes to age-related diseases (1–3). To counteract DNA damage, 
mammalian cells rely on a series of partially overlapping DNA re-
pair systems to remove DNA lesions that may block transcription 
or DNA replication. For bulky helix-distorting damage, such as the 
main ultraviolet (UV)–induced lesions, the principal repair mecha-
nism is the evolutionarily conserved nucleotide excision repair (NER) 
pathway (4, 5). NER operates via a “cut and patch” type of mecha-
nism involving ~30 proteins that recognize and remove helical dis-
tortions throughout the genome, i.e., global genome NER, or selectively 
from the transcribed strand of active genes, i.e., transcription- 
coupled NER (6, 7). In humans, defects in NER are causally linked to 
mutagenesis and cancer initiation as in the cancer-prone syndrome 
xeroderma pigmentosum (XP; complementation groups XP-A to 
XP-G) or to developmental and neuronal abnormalities as seen in a 
heterogeneous group of premature aging-like (progeroid) syndromes, 
including the Cockayne syndrome (affected genes: Csa and Csb), 
trichothiodystrophy (affected genes: Xpb and Xpd), or the XPF- 
ERCC1 syndrome (XFE; affected genes: Ercc1 and Xpf) (2). We and 
others have recently shown that DNA damage–driven inflamma-
tion contributes substantially in NER progeria and age-related de-
generative diseases, but the mechanisms remain unresolved (8–11). 
Xeroderma pigmentosum F - excision repair cross complemen-
tation group (XPF-ERCC1) is a heterodimeric, structure-specific 
endonuclease complex required for lesion excision in NER (4, 5) 
that plays an analogous role in the repair of highly cytotoxic DNA 
interstrand cross-links (ICLs) (12).
Using ERCC1-defective animal models of the human progeroid 
syndrome XFE (13), we show that persistent DNA damage leads to 
the premature onset of chronic pancreatitis in the DNA repair–
deficient animals. The gradual accumulation of irreparable DNA 
lesions triggers the formation of R-loops that causally contribute to 
the release and buildup of single-stranded DNA (ssDNA) fragments 
in the cytoplasm of cells, stimulating a viral-like immune response 
in progeroid Ercc1−/− and naturally aged pancreata. To lessen the 
proinflammatory load, we developed an extracellular vesicle (EV)–
based strategy to deliver recombinant ribonuclease (RNase) H or S1 
nuclease in inflamed Ercc1−/− pancreatic cells in vitro and in vivo. 
We find that treatment with the EV-delivered nuclease cargo rapidly 
removes R-loops and the ssDNA moieties in the cytoplasm of pan-
creatic cells, alleviating the proinflammatory response seen in 
progeroid Ercc1−/− animals. Thus, the development of rationalized 
intervention regimens against DNA damage–driven cytoplasmic 
ssDNAs may be a promising therapeutic strategy against chronic 
inflammation and tissue degeneration in NER progeria and likely 
during aging.
RESULTS
Persistent DNA damage associates with chronic  
pancreatitis in Ercc1−/− mice
DNA damage causally contributes to aging, as exemplified by the 
growing list of progeroid DNA repair–deficient syndromes with 
age-related metabolic and endocrine defects (1, 10, 14–16). To gain 
insight into the causal contribution of DNA damage in tissue- 
degenerative changes in the pancreas, we studied the pancreata of 
15-day-old DNA repair–deficient Ercc1−/− and age-matched wild-
type (wt) littermate control mice. Scanning and transmission elec-
tron micrographs (SEM and TEM) reveal loss-of-tissue architecture 
and fibrosis with frequent and significantly denser collagen fibrils, 
observed in the vicinity of stellate cells in Ercc1−/− pancreata (Fig. 1A) 
but not in the pancreata of the NER-defective Csbm/m, Xpa−/−, or 
Xpc−/−, known to manifest a milder phenotype, or the wt corre-
sponding control animals (fig. S1A). Fibrosis in Ercc1−/− pancreata 
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P = 0.026 P = 0.005 P = 0.0185
Fig. 1. Pancreatic fibrosis and inflammation in Ercc1−/− mice. (A) SEM (left) and TEM (right) of collagen (arrows) in wt and Ercc1−/− (Er1−/−) pancreas. N, nucleus; col, 
collagen; AC, acinar cell; SC, stellate cell. (B) Mmp9, Col1a, and Timp2 mRNA levels in Er1−/− and wt pancreata. (C) Infiltrated leukocytes (arrows) in wt and Er1−/− pancreata 
(SEM). (D) Immunostaining of CD45- and MAC1-positive cells infiltrating wt and Er1−/− pancreata (n = 3). (E) Ccl2, Il6, Cxcl10, Τnf, and Il1 mRNA levels in Er1−/− compared 
to wt pancreata (n = 3). (F) Plasma amylase levels [international units per liter (IU/liter)] in wt and Er1−/− mice. (G) Immunostaining of -SMA and VCAM1 in wt and Er1−/− 
pancreata (n = 3). (H) -SMA protein levels in wt and Er1−/− whole-cell pancreas extracts (n = 4). (I) Immunostaining of H2AX and (J) pATM in wt and Er1−/− PPCs (n = 3). 
(K) H2AX, pATM, and FANCI protein levels in of wt and Er1−/− whole-cell pancreas extracts (n ≥ 3). In (B) and (E), the red dashed lines depict the wt levels. The graphs in 
(D) and (G) represent the mean fluorescence intensity (MFI) per cubic micrometer of tissue; in (I) and (J), the percentage of positive-stained cells; and in (H) and (K), the 
-tubulin (-TUB)–normalized protein expression levels (n.e.l.) in Er1−/− pancreata compared to wt controls. All tissues and cells are derived from P15 mice. Scale bars, 
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is accompanied by an increase in the mRNA levels of collagen 1a 
(Col1a) and matrix metalloproteinase 9 (Mmp-9) genes and no changes 
in the mRNA levels of the tissue inhibitor of metalloproteinases 2 
(Timp2) gene (Fig. 1B). Likewise, we find a significant increase in 
the mRNA levels of Col1a and Mmp-9 genes in the pancreata of 
severely progeroid P15 Csbm/m;Xpc−/− double-mutant (DKO) mice. 
Consistently, our analysis revealed normative mRNA levels for the 
Timp2 gene in the DKO or single-mutant pancreata (fig. S1B). Fur-
ther SEM studies, as well as immunostaining against CD45 (for leu-
kocytes) or MAC1 (for macrophages), and quantitative polymerase 
chain reaction (qPCR) analysis reveal the presence of lymphocytic 
infiltrates (Fig. 1, C and D) and a significant increase in Ccl2, Il6, 
Cxcl10, Tnf-, and Il1 mRNA levels (Fig. 1E) in P15 Ercc1−/− pan-
creata compared to wt controls. Amylase, a pancreatic enzyme that 
catalyzes the hydrolysis of starch into smaller carbohydrate molecules, 
is typically released into the bloodstream in case of inflammation. 
We find that the pancreatic tissue amylase levels are comparable 
between Ercc1−/− and wt pancreata (fig. S1, C and D). However, the 
serum amylase levels are significantly lower in the DNA repair–
deficient animals compared to wt controls (Fig. 1F), indicating the 
premature onset of chronic pancreatitis and permanent tissue 
damage (17). Immunostaining and Western blotting for –smooth 
muscle actin (-SMA), a marker for the activation of pancreatic 
stellate cells, reveal the marked increase in -SMA protein levels in 
Ercc1−/− pancreata (Fig. 1, G and H) and in primary pancreatic cells 
(PPCs) (fig. S1E) compared to corresponding wt controls. Likewise, 
we find that the vascular cell adhesion molecule 1 (VCAM-1), a 
cytokine-inducible endothelial CAM, is overexpressed in Ercc1−/− 
pancreata (Fig. 1G). Phosphorylated histone H2AX (H2AX)–
containing foci accumulate at sites of DNA breaks (18). Consistently, 
the number of H2AX-positive nuclei was significantly higher in 
the DNA repair–defective Ercc1−/− PPCs (Fig. 1I) compared to wt 
control cells. We also find marked differences in the number of posi-
tively stained nuclei for pATM (phosphorylated ataxia talangiec-
tasia-mutated), a central mediator of the DNA damage response 
(DDR; Fig.  1J), and an increase in the protein levels of H2AX, 
pATM, as well as Fanconi anemia complementation group I (FANCI), 
known to be involved in the repair of DNA ICLs (Fig. 1K; as indi-
cated) (19). Thus, an inborn ERCC1 defect leads to persistent DNA 
damage accumulation associated with aberrant tissue morphological 
changes and chronic inflammation in Ercc1−/− pancreata.
Ercc1−/− pancreatic cells become senescent but show no 
signs of apoptosis
In response to DNA damage, mammalian cells undergo cellular 
senescence or apoptosis to suppress tumorigenesis (20). In situ 
detection of fragmented DNA assay [terminal deoxynucleotidyl 
transferase–mediated deoxyuridine triphosphate nick end labeling 
(TUNEL)] revealed no significant differences in the percentage of 
TUNEL-positive Ercc1−/− and wt PPCs (Fig. 2A and fig. S2A). Like-
wise, staining and Western blotting for cleaved caspase 3 detected 
few, if any, apoptotic cells in Ercc1−/− PPCs (Fig. 2, B and C). In 
support, the mRNA levels of Bcl2, Caspase 8, Bad, and Bcl_xl pro-
apoptotic genes are comparable in Ercc1−/− and wt pancreata (Fig. 2D). 
However, we find a higher number of annexin V (+)/propidium 
iodide (PI) (+) cells in Ercc1−/− pancreata, indicating the presence of 
ruptured cell membranes that typically associate with necrotic cell death 
(fig. S2B). Further analysis in Ercc1−/− pancreata revealed an increase 
in the mRNA levels of the senescence-associated cyclin- dependent 
kinase inhibitor P21 (Fig. 2E), a ~30% shorter telomere length 
(Fig. 2F), and an increase in the number of telomere dysfunction– 
induced foci (TIFs) (21), as evidenced by the higher number of 53BP1 
foci that colocalized with telomeres in Ercc1−/− PPCs (Fig. 2G), while 
Tert mRNA levels are comparable to wt controls (fig. S2C). Consistent 
with previous findings, further analysis of Ercc1−/− metaphase chro-
mosome spreads revealed that P15 PPCs do not accumulate telo-
mere fusions, indicating that the progeroid Ercc1−/− cells have not 
yet reached the critical telomere length (fig. S2D) (22). In P15 Ercc1−/− 
pancreata, we find a ~16-fold increase in lipofuscin pigment known to 
accumulate with aging (Fig. 2H) and a higher number of senescence- 
associated -galactosidase–positive (SA--gal+) Ercc1−/− cells com-
pared to corresponding wt controls (Fig. 2I). High-mobility group 
box 1 protein (HMGB1) is a ubiquitous damage-associated molecular 
pattern protein in the nucleus that promotes inflammation when 
released extracellularly (23, 24). We find a significant accumulation 
of HMGB1 in the cytoplasm and in the cellular membrane of 
Ercc1−/− PPCs compared to wt control cells (Fig. 2J). Consistent with 
the release of HMGB1 in the extracellular milieu of senescent cells 
(25), Western blotting reveals a decrease in the intracellular HMGB1 
protein levels along with a marked increase of HMGB1 protein 
levels in the culture media of Ercc1−/− PPCs (Fig. 3A). Together, our 
findings indicate that the DNA repair defect triggers cellular 
senescence and necrotic cell death but no apoptosis in Ercc1−/− 
pancreata and PPCs.
The ERCC1-XPF defect triggers a viral-like immune  
response associated with the accumulation of  
cytoplasmic ssDNA moieties
To assess the senescence-associated gene expression changes trig-
gered by persistent DNA damage in the pancreas signaling (26, 27), 
we performed RNA sequencing (RNA-seq) profiling in 15-day-old 
Ercc1−/− and age-matched wt pancreata. The analysis revealed 4403 
differentially expressed genes [meta–false discovery rate (FDR) ≤ 0.01, 
fold change ≥ ±1.5; 2405 up-regulated genes; 1998 down-regulated 
genes; data S1]. Within this set of genes, gene ontology classification 
was able to discern a set of seven biological processes containing a 
significantly disproportionate number of genes relative to those ex-
pected in the murine genome (FDR ≤ 0.05). These processes were 
ranked by their relative enrichment score (see Materials and Methods) 
and associated with cytokine production, antigen presentation, 
immune cell chemotaxis, and proinflammatory responses (Fig. 3B). 
Further analysis within the overrepresented biological processes re-
vealed the up-regulation of proinflammatory genes and genes asso-
ciated with leukocyte migration and extracellular matrix organization 
(Fig. 3C). qPCR confirmed the increase in the mRNA levels of 
several proinflammatory and interferon (IFN) response genes, i.e., 
Sting, Ifit1, Ifit2, Ifi206, Il1r1, Ifna, Ifitm1, Usp18, Cxcl10, Mx1, and 
Isg15 in Ercc1−/− pancreata (Fig. 3, D and E), as well as the increase 
in the mRNA levels of Sting, Ifitm1, Mx1, and Ifit1 genes in the pan-
creata of Csbm/m;Xpc−/− DKO mice (fig. S1B). Western blot analysis 
revealed an increase in the protein levels of pSTING (phosphorylated 
form of stimulator of IFN genes; Fig. 3F) and STING (fig. S3A) 
known to act as a sensor of cyclic deoxyguanosine monophosphate 
and as an adaptor protein mediating the IFN response, once activated 
by DNA sensors such as cGAS (8). Further analysis revealed an in-
crease in pSTAT1 (phosphorylated signal transducer and transcrip-
tion activator) protein levels, known to mediate the cellular response 
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Fig. 2. Er1−/− pancreatic cells present senescent, but not apoptotic, characteristics. (A) TUNEL in wt and Ercc1−/− (Er1−/−) PPCs (n = 3). (B) Immunostaining of cleaved 
(cl.) caspase 3 in wt and Er1−/− PPCs (n = 5). (C) Cleaved caspase 3 (casp3) in wt and Er1−/− pancreas whole-cell extracts. UV-irradiated (20 J/m2) wt BMDM protein extracts 
were used as positive control (+) (n = 3). (D) Bcl2, Casp8, Bad, and Bcl_xl mRNA levels in Er1−/− compared to wt pancreata (n = 3). (E) P21 mRNA levels in Er1−/− compared to 
wt pancreata (n = 5). (F) Telomere length in wt and Er1−/− pancreata compared to a single-copy gene (Rarb2). The graphs depict the standard curves for telomere (Tel) and 
Rarb (left) and the relative telomere to Rarb [telomere/single copy gene (T/S)] ratio in wt and Er1−/− pancreata (right, n = 4). ct, cycle threshold. (G) Immunofluorescence in 
situ hybridization of 53BP1 with telomeric DNA (TelG) in wt and Er1−/− PPCs. Arrows denote TIFs on telomeres. The graph depicts the mean percentage of cells containing 
≥2 TIFs ± SD, n = 3. (H) Lipofuscin staining, as depicted by GL13 binding (SenTraGor), in wt and Er1−/− pancreata (n = 3). (I) SA--gal assay in wt and Er1−/− PPCs (n = 3 
technical replicates). (J) Immunostaining of cytoplasmic HMGB1 in wt and Er1−/− PPCs (white arrows; n = 3). In (D) and (E), the red dashed lines represent the wt levels. 
The graphs in (H) and (I) depict the percentage of positive-stained cells and, in (J), cytoplasm-positive–stained cells. Tissues and cells are derived from P15 mice. Scale bars, 
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Fig. 3. Ercc1 deletion drives a viral-like response and cytoplasmic ssDNA accumulation. (A) HMGB1 in whole-cell extracts (w.c.e.) and in the culture media of wt and 
Er1−/− PPCs (n = 4). (B) Overrepresented biological processes (Gene Ontology) of the differentially expressed genes in Er1−/− compared to wt pancreata [meta–false discovery 
rate (FDR) ≤ 0.01, fold change ≥ ±1.5, n = 3]. Processes with up-regulated genes (green) and down-regulated genes (red). (C) Heatmaps of representative genes associated 
with inflammation, leukocyte migration, and extracellular matrix (ECM) organization up-regulated in Er1−/− (1 to 3) compared to wt (1 to 3) pancreata. (D) mRNA levels of 
selected overrepresented genes in wt and Er1−/− pancreata. (E) mRNA levels of overrepresented Ifn signature genes in wt and Er1−/− pancreata. (F) Phosphorylated STING 
(pSTING) and (G) phosphorylated STAT1 (pSTAT1) in whole-cell extracts of wt and Er1−/− pancreata (n = 3 to 4). (H) Immunostaining of ssDNA in wt and Er1−/− pancreas, 
(I) liver, and (J) kidney (n = 3). The graphs in (A), (F), and (G) represent the -TUB n.e.l. of proteins in wt and Er1−/− pancreata and, in (H) to (J), the MFI per cubic micrometer 
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The observed IFN response and the increase in the mRNA levels 
of several genes associated with nucleic acid sensing, i.e., Sting, Irf1, 
Ddx58, Ddx60, and Tlr3 (fig. S3B) (8), prompted us to test for the 
presence of DNA fragments in the cytoplasm of Ercc1−/− PPCs. 
Immunofluorescence (IF) studies with antibodies that are preferen-
tially reactive against ssDNA or double-stranded DNA (dsDNA) 
revealed the accumulation of cytoplasmic ssDNA moieties in the 
pancreas (Fig. 3H), liver (Fig. 3I), and kidney (Fig. 3J) of P15 
Ercc1−/− animals as well as in Ercc1−/− PPCs (fig. S3C) and in bone 
marrow–derived macrophages (BMDM) (fig. S3D). We find no 
evidence of cytoplasmic dsDNAs in Ercc1−/− PPCs (fig. S3E) or in 
the kidney (fig. S3F) and liver (fig. S3G) of Ercc1−/− mice. Further IF 
studies revealed that ssDNAs also accrue in the cytosol of the 
NER-defective Csbm/m and Xpc−/− pancreatic cells, albeit to a lesser 
extent (fig. S3H). Notably, we find that cytoplasmic ssDNAs also 
accumulate in the pancreata and livers of the 24-month-old naturally 
aged mice (Fig. 4, A and B) followed by an increase in the mRNA 
levels of proinflammatory and IFN response genes, i.e., Sting, Ifitm1, 
Mx1, Ifit1, Ccl2, Il1b, Tnf, Cxcl10, and Col1a (Fig. 4C); the latter is 
consistent with the immune response against cytosolic DNA frag-
ments (8). To further confirm the presence of cytoplasmic ssDNAs 
in Ercc1−/− PPCs, cells were treated with mung bean S1 endonuclease, 
which specifically degrades ssDNA, leaving the duplex DNA intact 
(29). Treatment with the S1 nuclease led to the complete removal of 
ssDNAs from the cytoplasm of Ercc1−/− PPCs (Fig. 4D).
DNA damage–induced R-loops trigger the accumulation 
of cytoplasmic ssDNAs
Owing to the DNA repair defect in Ercc1−/− pancreata, we reasoned 
that the presence of irreparable DNA lesions causally contribute to 
the generation of ssDNAs in the cytoplasm of Ercc1−/− PPCs. In 
support, treatment of wt PPCs with the potent genotoxin mitomycin 
(MMC), which generates DNA ICLs, or with UV-C irradiation 
(15 J/m2) led to the rapid accumulation of ssDNAs in the cytoplasm 
(fig. S4, A and B). Inactivation of ATM kinase with KU-55933 
inhibitor or of ataxia-telangiectasia and Rad3-related (ATR) kinase 
with NU6027 had no detectable impact on cytoplasmic ssDNAs in 
MMC- or UV-treated cells (fig. S4, A and B; as shown), indicating 
that the accumulation of cytoplasmic ssDNAs is driven by DNA 
damage itself and it does not require canonical DDR signaling. To 
further establish that nuclear DNA damage causally contributes to 
the release of ssDNAs in the cytoplasm, we isolated PPCs from 
cyclobutane pyrimidine dimer (CPD)–photolyase transgenic mice 
that ubiquitously express the marsupial CPD-specific photolyase 
transgene (30). The CPD photolyase can directly revert UV-induced 
CPDs into undamaged bases using visible light energy in a reaction 
known as photoreactivation. Exposure of CPD-photolyase trans-
genic PPCs to UV irradiation (15 J/m2) and subsequent incubation 
in the dark (CPD photolyase is inactive and UV-induced CPDs per-
sist) led to the accumulation of ssDNA moieties in the cytoplasm of 
these cells (Fig. 4E; as indicated). ssDNAs were absent when UV- 
treated, CPD-photolyase transgenic PPCs were also exposed to the 
photoreactivating light (photolyase is active and UV-induced CPDs 
are repaired) (Fig. 4E; as indicated). Further studies revealed that 
treatment of wt PPCs with Illudin S, a fungal sesquiterpene known 
to induce transcription-blocking DNA adducts, recapitulates the 
accumulation of cytoplasmic ssDNAs seen in Ercc1−/− PPCs or in 
MMC- and UV-treated PPCs (Fig. 4F), indicating that irreparable 
DNA lesions interfering with transcription may underlie the observed 
release of ssDNAs in the cytoplasm of PPCs. Persistent DNA lesions 
often hamper the progression of RNA polymerase II on actively 
transcribed genes, leading to the gradual buildup of R-loops in cells. 
In line, confocal microscopy studies revealed the accumulation of 
R-loops in Ercc1−/− and Illudin S–treated wt PPCs (Fig. 4G). Detection 
of RNA by the S9.6 antibody was recently shown to generate arti-
facts when imaging RNA:DNA hybrids (31). To exclude that the 
S9.6 IF signal observed arises from dsRNA rather than RNA:DNA 
hybrids, we transfected PPCs with the RNA:DNA hybrid–specific 
nuclease, RNase H; the latter removed RNA-DNA hybrids, leading 
to the substantial decrease of R-loops in these cells (Fig. 4G; as indi-
cated). Next, we sought to test whether DNA damage–driven R-loops 
causally contribute to the release of ssDNA moieties in the cytoplasm 
of Illudin S–treated and Ercc1−/− PPCs. Consistently, we find that 
ssDNAs are removed from the cytoplasm of Illudin S–treated or 
Ercc1−/− PPCs when these cells are transfected with RNase H to 
eliminate R-loops (Fig. 5A). Likewise, R-loops accumulate signifi-
cantly in MMC-treated PPCs (fig. S4C), and RNase H–mediated 
removal of R-loops leads to the substantial elimination of cytoplas-
mic ssDNAs in MMC-treated PPCs (fig. S4D). Consistent with the 
accumulation of cytoplasmic ssDNAs in the 24-month-old pancreata 
and livers, we find that R-loops also accumulate in the cell nuclei 
of pancreata, livers, and kidneys of the 24-month-old naturally aged 
mice compared to 2-month-old young adult animals (Fig. 5, B and C, 
and fig. S4E). In addition to the nuclear accumulation of R-loop 
structures, we find that RNA:DNA hybrids also accumulate in the 
cytoplasm pancreatic cells in 24-month-old kidneys and livers. How-
ever, this fraction is mostly colocalized with mitochondria (32). The 
S9.6 IF signal was efficiently removed by RNase H treatment but 
remained unaffected upon treatment with ribonucleases RNase A 
or T1, indicating that the signal is not derived from dsRNA or ssRNA 
moieties, respectively (fig. S4F). Cytosolic ssDNAs also accumulate 
in serum-starved or hydroxyurea-treated Ercc1−/− PPCs [1% fetal 
bovine serum (FBS); fig. S5, A and B], suggesting that DNA damage–
associated ssDNAs can accumulate in the cytoplasm of these cells 
independently of DNA replication.
To further explore the origin of cytoplasmic ssDNAs, we treated 
wt pancreatic cells with trans-retinoic acid (tRA) and Illudin S, to 
induce transcription of tRA-responsive genes, in the presence of 
transcription-blocking DNA lesions. We then performed qPCR on 
ssDNA fragments isolated from untreated and tRA/Illudin S–treated 
PPCs, where the second strand was synthesized with the Klenow 
fragment of DNA polymerase I (fig. S5C). Our analysis revealed the 
presence of ssDNAs originating from the tRA-inducible genes Rarb 
and Stra6 (33) in tRA/Illudin S–treated PPCs compared to untreated 
controls, indicating that cytoplasmic ssDNAs are generated by 
cotranscriptional R-loops. The -actin gene was used as a control 
because it is a tRA-nonresponsive gene that was previously shown 
to accumulate R-loops (34, 35). Next, we explored the possibility of 
long interspersed nuclear element 1 (LINE1) derepression by 
assessing LINE1 transcripts in wt and Ercc1−/− pancreata, as well as 
in untreated and tRA/Illudin S–treated PPCs (36). qPCR analysis 
revealed no evidence to support the presence of LINE1 open reading 
frame 1 (ORF1), ORF2, 5′ untranslated region (5′UTR), and 3′UTR 
transcripts (fig. S5D).
To further investigate how R-loops lead to the generation of 
ssDNAs, we used a DNA-RNA immunoprecipitation (DRIP) approach 
coupled to Western blotting, to isolate RNA:DNA hybrids from wt 















Chatzidoukaki et al., Sci. Adv. 7, eabj5769 (2021)     19 November 2021


































































































































































































































































































































Fig. 4. DNA damage–induced cytoplasmic ssDNA accumulation is instigated by R-loops. (A) Immunostaining of ssDNA in 2-month (2m)– and 24-month (24m)–old 
wt pancreata (n = 3). (B) IF detection of ssDNA in 2 month (2m)– and 24 month (24m)–old wt livers (n = 3). (C) mRNA levels of selected genes in 24-month-old wt pancreata. 
The red dashed line represents the levels in 2-month-old wt pancreata (n = 4 to 5). (D) Immunostaining of ssDNA (arrows) in wt and Ercc1−/− (Er1−/−) PPCs with or without 
S1 nuclease treatment (n = 3). (E) Immunostaining of cyclobutane-pyrimidine dimers (CPD) (left; red) or ssDNA (right; green) in untreated (untr.) CPD+ transgenic PPCs, 
UV-irradiated (15 J/m2) and kept in the dark or under white light (1.5 hours of incubation; n = 3). The graphs depict the percentage of CPD-positive–stained cells and the 
ssDNA MFI per cell, respectively. (F) Immunostaining of ssDNA in untreated and Illudin S–treated (IllS) (30 ng/ml; 3 hours) wt PPCs (n = 4). (G) Immunostaining of R-loops 
(S9.6 antibody) in Er1−/− and untreated or Illudin S–treated (30 ng/ml; 3 hours) wt PPCs in the absence or presence of transfected recombinant RNase H (n = 3). The graphs 
in (A) and (B) depict the MFI per cubic micrometer of tissue; in (D) and (F), the MFI per cell; and in (G), the MFI per nucleus. Unless otherwise stated, tissues and cells are 
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Fig. 5. RPA mediates the nucleocytoplasmic transport of ssDNA moieties. (A) Immunostaining of ssDNA in Ercc1−/− (Er1−/−) and untreated or Illudin S–treated wt PPCs 
in the absence or presence of transfected recombinant E. coli RNase H (n = 3 to 4). (B) Immunostaining of R-loops, by means of S9.6 antibody staining, in 2- and 24-month-old 
naturally aged pancreata in the absence or presence of transfected recombinant RNase H (n = 3). (C) S9.6 immunostaining of R-loops in 2- and 24-month-old livers in the 
absence or presence of transfected recombinant RNase H (n = 3). (D) S9.6 immunoprecipitation (DRIP) followed by Western blotting for XPG, XPF, RNase H1 (RNH1), and 
DNA topoisomerase 1 (TOP1) in wt and Er1−/− pancreatic nuclear extracts with and without RNase H (RH) treatment (n = 6). (E) Immunostaining of ssDNA (green) in Er1−/−, 
untreated, MMC- (10 g/ml; 4 hours), and Illudin S–treated (30 ng/ml; 3 hours) wt PPCs, cultured with or without the nuclear export inhibitor leptomycin B (LMB; 40 nM). 
Image inlays show the nuclear ssDNA signal (green) (n = 3). The graphs depict the MFI per cell in (A), per nucleus in (B) and (C), and per cytoplasm in (E). Unless otherwise 
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agreement with previous findings, this approach revealed that XPG 
(xeroderma pigmentosum G) and XPF nucleases are bound togeth-
er with DNA topoisomerase 1 (TOP1) to R-loops in wt and Ercc1−/− 
pancreatic cells (Fig. 5D and fig. S5E; as indicated) (33, 37, 38). Our 
finding that, in Ercc1−/− cells, the XPF DRIP signals are lower than 
those of XPG supports previous observations indicating that XPF is 
unstable in the absence of ERCC1 (39, 40). The latter makes XPF 
the limiting factor during the endonuclease-mediated resolution of 
R-loops in Ercc1−/− cells. Consistent with the increased amount of 
RNA:DNA hybrids in Ercc1- deficient pancreata (Fig. 4G), we also 
find higher levels of RNase H1 bound to R-loops in Ercc1−/− cells 
compared to wt controls (Fig. 5D and fig. S5E; as indicated).
ssDNAs are released into the cytoplasm via an active 
nucleocytoplasmic transport mechanism
Micronuclei containing whole or fragmented chromosomes may 
passively diffuse into the cytoplasm when the nuclear envelope 
breaks down in mitotically dividing cells (41). The lack of 4′,6- 
 diamidino-2-phenylindole (DAPI)–stained chromatin fragments 
in the cytoplasm of Ercc1−/− PPCs along with the presence of cyto-
plasmic ssDNAs in hydroxyurea-treated Ercc1−/− PPCs or in 
Ercc1−/− livers and kidneys, where the great majority of cells typically 
do not divide, prompted us to test whether ssDNAs are actively 
released in the cytoplasm of Ercc1−/− cells. Analysis of nucleocyto-
plasmic protein shuttling is greatly facilitated by the use of leptomy-
cin B (LMB), an inhibitor of CRM1-dependent nuclear export that 
does not interfere with protein transport into the nucleus. We find 
that treatment of Ercc1−/− PPCs and MMC- or Illudin S–treated wt 
PPCs with LMB leads to the marked decrease of ssDNAs in the 
cytoplasm that concurrently accumulate in the nuclei of these cells 
(Fig. 5E and fig. S5F). This finding suggests that cytoplasmic ssDNAs 
are of nuclear origin and that they are released into the cytoplasm of 
DNA repair–deficient cells via an active nucleocytoplasmic transport 
mechanism. Replication protein A (RPA) binds preferentially to ssDNA 
during DNA replication, repair, or recombination in eukaryotic 
cells (42). Western blotting of nuclear and cytoplasmic protein ex-
tracts in wt and Ercc1−/− pancreata revealed that RPA70, the DNA 
binding subunit of RPA (from now on referred to as RPA), is located 
both in the nucleus and the cytoplasm of Ercc1-deficient PPCs 
(Fig. 6A). We find that RPA binds cytoplasmic ssDNAs in Ercc1−/− 
PPCs and that the RPA-ssDNA interaction is abolished when 
Ercc1−/− PPC cytoplasmic protein extracts are treated with the mung 
bean S1 nuclease (Fig.  6B). Consistently, we find higher levels of 
RPA bound to ssDNA in the cytoplasm of MMC-treated compared 
to untreated PPCs (fig. S5G), as indicated by anti-ssDNA immuno-
precipitation experiments in cytoplasmic extracts of equal quantity. 
Next, we performed a small interfering RNA (siRNA)–mediated 
knockdown of RPA to test for the functional relevance of RPA to 
the accumulation of cytoplasmic ssDNAs in Ercc1−/− PPCs (Fig. 6C). 
We find that RPA knockdown limits substantially the accumulation 
of ssDNAs in the cytoplasm of Ercc1−/− PPCs (Fig. 6D). Thus, DNA 
damage–driven ssDNAs are bound by RPA and are actively trans-
ported to the cytoplasm. Inhibition of nuclear export or abrogation 
of RPA via RNA interference–mediated knockdown substantially 
impedes their release and accumulation in the cytoplasm.
To further investigate the kinetics of R-loop–induced cyto-
plasmic ssDNA accumulation and genome instability, we treated wt 
PPCs with tRA and Illudin S to induce transcription in the presence 
of transcription-blocking DNA lesions. Next, we performed a series 
of IF studies for genome-bound and cytoplasmic RPA70, cytoplasmic 
ssDNA, RNA:DNA hybrids, and H2AX+;53BP1+ foci (fig. S6, A to F). 
Using a preextraction, fixation, and immunostaining approach, we 
find that, upon tRA/Illudin S treatment, the genome-bound RPA70 
mean fluorescence intensity (MFI) levels increase over time until 
the 16-hour time point and remain stable thereafter (fig. S6A). Sim-
ilar kinetics were observed for cytoplasmic RPA70, whose MFI levels 
were measured in the presence of cyclohexamide to exclude any 
signal derived from newly translated protein (fig. S6B). Consistently, 
we find that cytoplasmic ssDNAs reach their maximum MFI levels 
at 16 hours of treatment (fig. S6C). These findings are in agreement 
with a previous work on the global exhaustion of RPA (43) and in-
dicate that, as RPA-bound ssDNA is translocated into the cytoplasm, 
less RPA70 becomes available to bind the continuously increasing 
amount of R-loops (fig. S6D), further contributing to genome insta-
bility (fig. S6E). The latter is expected to lead to increasing amounts 
of RPA70-free ssDNA moieties, which will not be transferred into 
the cytoplasm (fig. S6, B and C). Similar findings were observed in 
tRA/Illudin S–treated cells cultured in the presence of ATR inhibi-
tor (ATRi). In this condition, RNA:DNA hybrids continue to accu-
mulate, generating more H2AX+;53BP1+ foci, further contributing 
to DNA damage (fig. S6, A to F).
An EV-based nuclease cargo eradicates cytoplasmic ssDNAs 
and the proinflammatory response in Ercc1−/− pancreata
Cells respond to cytosolic DNA introduced into the cytoplasm by 
triggering an innate immune response. We, therefore, reasoned that 
the removal of ssDNAs from the cytoplasm of Ercc1−/− PPCs would 
be beneficial for reducing the proinflammatory load in inflamed cells, 
thereby improving the outcome of chronic pancreatitis in Ercc1−/− 
mice. To test this, we first transiently transfect recombinant mung 
bean S1 nuclease into MMC-treated wt PPCs and corresponding 
untreated control cells. We find that mung bean S1–mediated deg-
radation of MMC-induced ssDNAs (Fig. 6E) prevents the nuclear 
translocation of nuclear factor B (NF-B), a potent regulator of the 
innate immune response against foreign pathogens (Fig. 6F) (44). 
Moreover, the nuclease-mediated removal of cytosolic ssDNAs lowers 
the Ιfn mRNA levels compared to those observed in untreated 
wt cells (Fig. 6G). Thus, removal of cytosolic ssDNAs substantially 
dampens the proinflammatory response seen in Ercc1−/− PPCs.
EVs are lipid bilayer–delimited particles that are produced in the 
endosomal compartment of most eukaryotic cells and are important 
drivers of intercellular communication. EVs are released into the 
bloodstream and are known to discharge their content into far distant 
recipient cells and tissues to exert multiple physiological stimuli 
(45). First, we used an EV-based strategy to deliver recombinant S1 
nuclease to remove the cytoplasmic ssDNAs in Ercc1−/− PPCs. We 
find that treatment with naive (i.e., not loaded) or mung bean S1 
nuclease-loaded EVs substantially diminishes the accumulated 
ssDNAs in the cytoplasm of Ercc1−/− PPCs (Fig. 7A). Next, we em-
barked on a physiological application by injecting intraperitoneally 
P15 Ercc1−/− mice with naive or mung bean S1 nuclease-loaded EVs 
for five consecutive days (Fig. 7B). We find that treatment of 
Ercc1−/− mice with EV-based S1 nuclease cargo leads to the substan-
tial removal of cytoplasmic ssDNAs (Fig. 7C). To test that cytoplasmic 
ssDNAs in Ercc1−/− pancreata causally contribute to the observed 
IFN response (Figs. 3E and 7C), we next prepared National Insti-
tutes of Health (NIH) 3T3–derived EVs carrying the cytoplasmic 
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pancreata. Consistently, we find a substantial increase in the Ifna 
mRNA levels of PPCs treated for 24 hours with EVsErcc1 cyto but not 
with EVswt cyto. Ifna mRNA levels substantially decrease when PPCs 
are treated with EVsErcc1 cyto carrying cytoplasmic DNA already 
pretreated with the mung bean S1 nuclease but not with the RNase 
A (Fig. 7D; as indicated). Our finding that DNA damage–driven 
R-loops causally contribute to the release of cytoplasmic ssDNAs in 
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Fig. 6. In vitro and in vivo effect of ssDNA abrogation in Er1−/− pancreata. (A) RPA70 in nuclear and cytoplasmic extracts from wt and Er1−/− pancreata (n = 4). 
(B) Immunoprecipitation (IP) using anti-ssDNA in untreated or S1 nuclease–treated cytoplasmic extracts from Er1−/− pancreata for RPA70. The input (INP) and flow 
through (FTH) are 1/20 of the extract used (n = 3). (C) RPA70 in whole-cell extracts of wt and Er1−/− PPCs, untreated, or incubated with scrambled (sictrl) or siRNA against 
Rpa70 (siRPA70) (n = 4). (D) Immunostaining of ssDNA in wt and Er1−/− PPCs, untreated, or incubated with scrambled (sictrl) or siRNA against Rpa70 (siRPA70) (n = 3). 
(E) Immunostaining of ssDNA upon recombinant S1 nuclease transfection in untreated and MMC-treated (10 g/ml; 4 hours) wt PPCs (n = 3). (F) Immunostaining of NF-B 
upon recombinant S1 nuclease transfection in untreated and MMC-treated (10 g/ml; 4 hours) wt PPCs (n = 3). (G) Ifn mRNA levels in MMC-treated wt PPCs, untreated, 
or transfected with S1 nuclease (n = 5). The graphs in (A) and (C) represent the -TUB– or fibrillarin (FBL)–normalized expression of RPA70 levels (n.e.l.) in Er1−/− compared 
to corresponding wt controls, as indicated. The graphs in (D) to (F) depict the MFI per cell. All tissues and cells are derived from P15 mice. Scale bars, 5 m. Error bars indicate 
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delivery of recombinant RNase H could remove R-loops and the 
accumulated cytosolic ssDNAs in Ercc1−/− pancreata. Intraperitoneal 
injections of P15 Ercc1−/− mice with naive or recombinant Escherichia 
coli RNase H–loaded EVs for two consecutive days revealed the 
substantial removal of R-loops (Fig.  7E), leading to a decrease in 
cytoplasmic ssDNAs (Fig. 7F) in Ercc1−/− pancreata. We found that 
treatment of Ercc1−/− mice with EVs carrying RNase H together 











































































































































































































































































































Fig. 7. Delivery of an EV-mediated nuclease cargo alleviates the proinflammatory response in Er1−/− pancreata. (A) Immunostaining of ssDNA in Er1−/− PPCs 
exposed to naive or EVs loaded with S1 nuclease (S1 EVs) (n = 3). (B) Experimental design of injections in wt or Er1−/− mice, with NIH cell line–derived naive or S1 EVs. 
(C) Immunostaining of ssDNAs in PPCs from Er1−/− mice injected with naive or S1 EVs (n = 3). (D) Ifn mRNA levels in wt PPCs treated with EVs carrying the cytoplasmic 
nucleic acid fraction from wt (wt cyto) or Er1−/− (Er1−/− cyto) pancreata, treated with S1 nuclease (+S1) or RNase A (+RA) (n = 3). Cyt/sm, cytoplasm. (E) S9.6 immunostaining 
in PPCs from Er1−/− mice injected with naive or EVs loaded with RNase H (RH EVs) (n = 3). (F) Immunostaining of ssDNA in PPCs from Er1−/− mice injected with naive or RH 
EVs (n = 3). (G) Ifn, mmp9, and p21 mRNA levels from pancreata of wt and Er1−/− mice injected with naive or S1 EVs (n ≥ 3). (H) -SMA (n = 5) and STING (n = 3) protein 
levels in pancreas whole-cell extracts of Er1−/− mice injected with naive or S1 EVs (-TUB–normalized). (I) A schematic graph on the functional contribution of DNA dam-
age–driven R-loops in chronic inflammation. The graphs depict MFI per cell in (A), (B), and (F) and MFI per nucleus in (E). The red dashed lines in (D) and (G) represent the 
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RNA:DNA hybrids and cytoplasmic ssDNA fragments, compared 
to animals treated with naive EVs or EVs loaded with scramble 
protein (fig. S6, G and H). Similar to PPCs, treatment of Ercc1−/− 
mice with S1 nuclease– or RH + S1–loaded EVs leads to the marked de-
crease in the mRNA levels of Ifna, Mmp9, and P21 genes (Fig. 7G 
and fig. S6I; as indicated) and to the substantial decrease in the pro-
tein levels of -SMA and STING in Ercc1−/− pancreata (Fig. 7H). 
Thus, DNA damage–driven R-loops trigger the accumulation of 
cytoplasmic ssDNAs leading to the activation of proinflammatory 
responses associated with chronic inflammation in Ercc1−/− pan-
creata. An EV-based delivery of S1 nuclease and/or RNase H cargo 
in mice can eliminate cytoplasmic ssDNAs, reducing the proin-
flammatory load in Ercc1−/− PPCs and pancreata. The latter has 
important ramifications for the development of efficient rationalized 
intervention strategies against chronic inflammation in NER progeria 
and likely also with aging (Fig. 7I).
DISCUSSION
Whereas the links between genome instability and enhanced cancer 
predisposition are well established, less is known about how DNA 
damage leads to the premature onset of age-related pathological 
features in man and accompanied animal models with mutations in 
DNA repair genes. Here, we provide evidence that persistent DNA 
damage triggers the formation of R-loops, leading to the accumula-
tion of cytoplasmic ssDNA moieties in Ercc1−/− pancreata or cells 
exposed to genotoxins. In turn, the presence of ssDNA fragments in 
the cytoplasm stimulates a proinflammatory response, leading to 
the premature onset of chronic pancreatitis and fibrosis in progeroid 
Ercc1−/− mice. In this work, cytosolic ssDNAs also accrue in inflamed 
naturally aged pancreata where fibrosis and chronic pancreatitis are 
known to be frequently observed with aging (46). Treatment with 
EVs carrying RNase H or S1 nucleases removes DNA damage–
induced R-loops and the associated cytoplasmic ssDNAs substan-
tially diminishing the proinflammatory response seen in progeroid 
Ercc1−/− pancreata.
DDR signaling is not required for the generation of cytoplasmic 
ssDNAs upon DNA damage as inhibition of ATM or ATR has no 
impact on the accumulation of ssDNA moieties in MMC- or UV- 
treated cells, respectively. However, the light-dependent removal of 
UV-induced CPDs from the genome of CPD-photolyase transgenic 
cells rapidly eliminates the great majority of cytosolic ssDNAs, indi-
cating that cytoplasmic ssDNAs are of nuclear origin. We and others 
have recently shown that R-loops are increasingly formed in cells 
that are defective in DNA repair or RNA processing (47–49)—leading 
to DNA breaks (50), transcription stalling, and DDR activation—
and that XPG and XPF are recruited on RNA:DNA hybrids under 
conditions that promote R-loop formation (33, 50). A central aspect 
of these findings is that the great majority of ssDNAs in the cyto-
plasm originate from DNA damage–driven R-loops. In support, 
mutations in RNase H2 that impair the efficient processing of RNA-
DNA hybrids or ribonucleotides are known to trigger the activation 
of a robust proinflammatory response (51). Moreover, a defect in 
the R-loop processing enzyme SAM and HD domain containing 
deoxynucleoside triphosphate triphosphohydrolase 1 (SAMHD1) was 
recently shown to trigger DNA replication fork–induced ssDNAs, 
genome instability, and inflammation (52).
Once generated, we find that ssDNAs are actively transported 
into the cytosol of pancreatic cells, bound by RPA. The latter could 
reflect a physiological response of the nucleus to remove by-products 
of DNA damage repair or irreversibly damaged genome fragments. 
Alternatively, ssDNAs may also be passively diffused into the cyto-
sol of mitotically dividing cells when the nuclear envelope breaks 
down (41). Besides the nucleus, we find that RNA-DNA hybrids 
also accumulate in the cytoplasm of naturally aged liver, kidney, 
and pancreas cells. Endogenous RNA:DNA hybrids are known to 
be regulated by RNA polymerase III in human cells (53) and could 
be attributed to R-loops, to reverse-transcribed retroelements arising 
upon DNA damage (51, 54), or else, from the mitochondrial genome 
(55, 56). Previous work on the enzymatic removal of cytoplasmic 
RNA:DNA hybrids did not rescue the proinflammatory response, 
indicating that cytoplasmic RNA:DNA hybrids do not contribute 
in innate immune activation (51). We find no evidence of apopto-
sis in Ercc1−/− pancreatic cells. Instead, the DNA repair–deficient 
cells show marked signs of senescence. Upon DNA damage, senescent 
cells are known to secrete high levels of inflammatory cytokines 
and immune modulators associated with the senescence-associated 
secretory phenotype (SASP) response (26). SASP and the gradual 
buildup of immunogenic ssDNAs in the cytoplasm of pancreatic 
cells could further perpetuate the vicious cycle of DNA damage–
driven immune activation, leading to the infiltration of immune cells, 
chronic inflammation, and fibrosis in Ercc1−/− pancreata.
So far, the lack of knowledge on the causal mechanisms under-
lying DNA damage–driven inflammation has hindered the devel-
opment of rationalized intervention strategies against degenerative 
diseases, especially at older ages. EVs are nonimmunogenic carriers, 
allowing their therapeutic cargo to circulate for extended periods of 
time within the body (45). Here, we developed an EV-based thera-
peutic strategy aiming at diminishing chronic inflammation due to 
the improper accumulation of ssDNAs in the cytoplasm of damaged 
cells and prevent disease. In Ercc1−/− pancreata, we find that treating 
mice with EVs carrying the ssDNA-specific S1 nuclease is equally 
effective in reducing the proinflammatory signal with EVs carrying 
the RNA-DNA hybrid–specific RNase H. Thus, as DNA damage–
driven R-loops and associated cytoplasmic ssDNA moieties accumu-
late over time, the proposed therapeutic scheme may be a promising 
strategy to combat chronic inflammation, thereby improving con-




The generation and characterization of NER-deficient mice have 
been previously described (13, 58). Animals were kept on a regular 
diet and housed at the Institute of Molecular Biology and Biotech-
nology (IMBB) animal house, which operates in compliance with 
the “Animal Welfare Act” of the Greek government, using the “Guide 
for the Care and Use of Laboratory Animals” as its standard. As 
required by the Greek law, formal permission to generate and use 
genetically modified animals was obtained from the responsible 
local and national authorities. All animal studies were approved by 
an independent Animal Ethical Committee at the Foundation of 
Research and Technology - Hellas (FORTH).
Primary cells and treatments
PPCs were isolated from P15 animals. Briefly, pancreata were ex-
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37°C for 15 min. After centrifugation, cells were resuspended and 
cultured in standard medium containing Dulbecco’s modified 
Eagle’s medium supplemented with 10% FBS, streptomycin (50 g/ml), 
penicillin (50 U/ml) (Sigma-Aldrich), and 2 mM l-glutamine 
(Gibco) for 2 days. In BMDM cell cultures, the medium was supple-
mented with 30% L929-conditioned culture media for 5 days. For 
subsequent experiments, cells were rinsed with phosphate-buffered 
saline (PBS); exposed to UV-C irradiation (10 to 20 J/m2), MMC 
(10 g/ml, 4 hours; AppliChem), Illudin S (30 ng/ml, 3 hours; Santa 
Cruz Biotechnology), and hydroxyurea (650 M, 16 hours); and 
cultured at 37°C before subsequent experiments. Preincubation 
with ATM inhibitor (10 M; Millipore), ATRi (10 M; Millipore), 
and LMB (40 nM; Merck) started 1 hour before genotoxic treatments 
and lasted throughout the experiment.
Protein transfection and EV injections
For the protein transfection experiments (Pierce Protein Transfec-
tion Reagent, Thermo Fisher Scientific), 10 U of recombinant mung 
bean S1 nuclease (100 U/l; Thermo Fisher Scientific) or RNase H 
(5 U/l; New England Biolabs) was used according to the manufac-
turer’s instructions. For the RPA70 knockdown, 20 pmol of a stealth 
RNA oligo was used (MSS 229016, Thermo Fisher Scientific). PPCs 
were transfected with Lipofectamine 2000 (Invitrogen) and subse-
quently seeded in 6-well or 24-well plates, according to the manu-
facturer’s protocol. As a nontargeting control, the AllStars negative 
(Qiagen) was used. For protein cell extracts, tissues were digested 
with collagenase (2.5 mg/ml) at 37°C for 15 min. Collagenase was 
neutralized with 10% FBS, and samples were further washed with 
1× PBS/1% bovine serum albumin (BSA). For the delivery of EVs, 
13-day-old Er1−/− mice were injected intraperitoneally every 24 hours 
for 5 days with EVs isolated from media of 10 × 106 NIH-3T3 cells. 
EVs were purified using the differential ultracentrifugation proto-
col (33, 59). Briefly, culture medium was centrifuged sequentially at 
300g (10 min), 2000g (10 min), and 10,000g (30 min) to remove 
dead cells and cell debris. EVs were purified with the final step of 
ultracentrifugation at 100,000g for 2 hours. For functional experi-
ments, the EVs used were purified from cells at a quantity of five 
times the number of recipient cells. S1 nuclease and/or RNase H or 
RNase A (1 mg/ml; Santa Cruz Biotechnology) was loaded using 0.2% 
saponin. The EVs were then centrifuged for 1.5 hours at 100,000g to 
ensure the incorporation of the nuclease, passed from a 0.2-m fil-
ter, and were injected intraperitoneally to mice. For the isolation of 
cytoplasmic DNA, wt and Ercc1−/− pancreata were lysed with NP-40 
lysis buffer [10 mM tris-HCl (pH 7.9), 10 mM NaCl, 3 mM MgCl2, 
0.5% NP-40, and protease inhibitors]. Cytoplasmic lysates were in-
cubated with 0.2 M NaCl and proteinase K (0.1 mg/ml) per 50 g of 
protein for 2 hours at 65°C. For the purification of DNA, the cyto-
plasmic extracts were loaded on phaselock tubes, with an equal 
volume of phenol/chloroform/isoamyl alcohol (25:24:1) and incu-
bated for 5 min at room temperature (RT) on a rotating wheel. The 
samples were centrifuged for 5 min at RT. The aqueous phase was 
isolated and incubated for 3 hours at −80°C with 0.2 M NaCl and 
2.5 volumes of cold 100% ethanol. The samples were centrifuged for 
25 min at 4°C. Eighty percent of ethanol was added to the pellet and 
centrifuged for 5 min at 4°C. The DNA pellets were air-dried. DNA 
(2.5 g) was treated with 1 l of S1 nuclease (100 U/l) or 1 l of 
RNase A (100 g/l) and incubated for 2 hours at 37°C. The DNA 
was loaded to the EVs using 0.2% saponin and incubated with the 
PPCs for 24 hours.
Immunofluorescence
For IF experiments of mouse tissues, minced tissues or cells were 
fixed in 4% formaldehyde, permeabilized with 0.5% Triton X-100, 
and blocked with 1% BSA. After overnight incubation with primary 
antibodies, secondary fluorescent antibodies were added, and DAPI 
was used for nuclear counterstaining. Samples were visualized with 
an SP8 TCS laser scanning confocal microscope (Leica), and scanned 
sections were analyzed using the Fiji (ImageJ) software. Mouse livers, 
kidneys, and pancreata were embedded in optimal cutting tempera-
ture (OCT) compound, before frozen sectioning on a Cryotome 
CM 1850, permeabilization, blocking, and immunostaining as de-
scribed above. For the SA--gal activity, the -gal assay kit was used 
(Abcam Inc., ab65351) according to the manufacturer’s instruc-
tions. Briefly, Er1−/− and wt PPCs were fixed, washed with PBS, and 
stained in -gal fixative solution at 37°C until -gal staining became 
visible in either experimental or control plates (3 hours). Cells were 
washed in PBS, and -gal–positive cells were counted in random fields 
in triplicate wells. For SenTraGor staining, cells were treated accord-
ing to the manufacturer’s instructions (Arriani Pharmaceuticals, 
AR8850020). Briefly, fixed differentiated PPCs were washed with 
50 and 70% EtOH incubated with SenTraGor reagent at RT, washed 
in EtOH, and incubated with primary anti-biotin antibody and 
fluorochrome-labeled secondary antibody. Cells were washed in 
PBS, and the lipofuscin-positive cells were counted in random fields 
in each of the six individual repeats using Fiji software.
SDS–polyacrylamide gel electrophoresis
For SDS–polyacrylamide gel electrophoresis (PAGE) analysis, cells 
were pelleted and tissues from Er1−/− and wt animals were ho-
mogenized in sucrose buffer [0.32 M sucrose, 15 mM Hepes-KOH, 60 
mM KCl, 2 mM EDTA, 0.5 mM EGTA, 0.5% BSA, 0.1% NP-40, and 
protease inhibitors (pH 7.9)]. Cell pellets were washed three times 
with 1× PBS. Cell pellets were then resuspended in NP-40 lysis 
buffer [10 mM tris-HCl (pH 7.9), 10 mM NaCl, 3 mM MgCl2, 0.5% 
NP-40, and protease inhibitors] and incubated for 10  min at 
4°C. After centrifugation, the supernatant was kept as the cytoplasmic 
fraction, and pellets were resuspended in high-salt extraction buffer 
[10 mM Hepes-KOH (pH 7.9), 380 mM KCl, 3 mM MgCl2, 0.2 mM 
EDTA, 20% glycerol, and protease inhibitors] and incubated for 
60 min at 4°C. The supernatant after centrifugation was kept as the 
nuclear fraction. For whole-cell extract preparations, cell pellets 
were resuspended in 150 mM NaCl, 50 mM tris (pH 7.5), 5% glycerol, 
1% NP-40, and 1 mM MgCl and incubated on ice for 20 min.
Antibodies
Antibodies against FANCI (H102; IF: 1/50), amylase (G-10; WB: 
1/500, IF: 1/100), goat anti-rat immunoglobulin G (IgG)–CFL 647 
(sc-362293; IF: 1/1000), translocase of outer membrane, subunit 20 
(TOM20) (sc-17764; IF: 1/100), XPF (sc-398032; WB: 1/500), and 
donkey anti-goat IgG–horse radish peroxidase (HRP) (sc-2020; WB: 
1/5000) were from Santa Cruz Biotechnology. Antibodies against 
ssDNA (MAB3299; IF: 1/70, IP: 5 g/1.5 mg of protein), dsDNA 
(MAB1293; IF: 1/100), S9.6 (MABE1095; IF: 1/100, DRIP: 8 g/5 g 
of DNA), H2AX (05-636; IF: 1/12,000), goat anti-rabbit IgG-
HRP (AP132P; WB: 1/10,000), and goat anti-mouse IgG-HRP 
(AP124P; WB: 1/10,000) were from Millipore. -SMA (ab5694; WB: 
1/500, IF: 1/50), HMGB1 (ab18256; WB: 1/1000, IF: 1/150), H2AX 
(ab22551; WB: 1/500), GAPDH (glyceraldehyde phosphate dehy-
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1/2500), and -tubulin (ab6046; WB: 1/1000) were from Abcam; 
cleaved caspase 3 (#9661; IF: 1/50, WB: 1/500), NF-B p65 (#8242; 
WB: 1/500, IF: 1/100), pATM (#S1981; IF: 1/100), STING (#13647S; WB: 
1/400), pSTING (#72971S; WB: 1/400), and pStat1 (#13647S; 
WB: 1/500) were from Cell Signaling Technology. VCAM (P8B1; 
IF: 1/200), CD45 (H5A5; IF: 1/200), and MAC1 (M1/70.15.11.5.2; 
IF: 1/200) were from the Developmental Studies Hybridoma Bank. 
53BP1 (NB100-304; IF: 1300), RPA70 (NB100-2204; WB: 1/1000), 
TOP1 (NBP1-30482; WB: 1/1000), and goat anti-mouse IgM 550 
(NB120-9167R; IF: 1/200) were from Novus Biologicals. Goat anti- 
mouse IgG Alexa Fluor 488 (A-11001; IF: 1/2000), goat anti-mouse 
IgG Alexa Fluor 555 (A-21422; IF: 1/2000), donkey anti-rabbit IgG 
Alexa Fluor 488 (A-21206; IF: 1/2000), donkey anti-rabbit IgG 
Alexa Fluor 555 (A-31572; IF: 1/2000), goat anti-rat IgG Alexa 
Fluor 555 (A-21434; IF: 1/2000), XPG (PA5-102437; WB: 1/1000), 
and DAPI (62247; IF: 1/20,000) were from Thermo Fisher Scientific, 
and CPD (TDM-2; IF: 1/50) was from Cosmo Bio. Antibody against 
RNase H1 (15606-1-AP; WB: 1/500) was from ProteinTech. Antibody 
against TRF1 (PA5-28423; IF: 1/100) was from Invitrogen.
SEM and TEM
For SEM, fresh pancreata were cut into small blocks. The tissue was 
fixed for 2 hours with 2% paraformaldehyde (PFA)–2% glutaraldehyde 
in 0.1 M sodium cacodylate buffer (pH 7.42). Samples were postfixed 
overnight in 1% osmium tetroxide (OTO method) and dehydrated 
in a graded series of ethanol. Specimens were coated in gold, mounted 
on aluminum stubs, and examined with a JEOL JSM6390 LV 
SEM (Peabody, MA) using an accelerating voltage of 15 kV. For 
TEM, pancreata were washed in PBS and fixed in 2% PFA–2% glu-
taraldehyde in 0.1 M sodium cacodylate buffer (pH 7.42) with 0.1% 
magnesium chloride and 0.05% calcium chloride. Afterward, the tissue 
was washed with sodium cacodylate buffer, the samples were fixed in 
1% osmium tetroxide in sodium cacodylate buffer, and samples were 
dehydrated in ethanol gradient. Samples were then treated with propylene 
oxide and embedded in an epon/araldite resin mix. Ultrathin sec-
tions (50 to 100 nm) were taken on a Leica LKB2088 ultramicrotome 
and were examined under JEM 100C/JEOL/Japan TEM. Microphoto-
graphs were obtained with an ES500W Enlangshen camera and pro-
cessed with the Digital Micrograph software (Gatan, Germany).
Annexin V–PI FACS analysis
Pancreata from 15-day-old Er1−/− and wt (n = 3) were minced and 
digested in 1× PBS/1% BSA/0.1% NaN3/collagenase (2.5 mg/ml). 
Homogenized tissue was further washed twice with ice-cold PBS 
and passed through a 100 Μ wire mesh. The cells (106/ml) were re-
suspended in 1× binding buffer. Cells (105) were used for the staining, 
and 5 l of annexin V–fluorescein isothiocyanate and 5 l of PI were 
added per sample. The cells were vortexed gently and incubated for 
15 min at RT in the dark. Four hundred microliters of 1× binding 
buffer was added to each sample. A FACSCalibur (BD Biosciences) 
was used, and data were analyzed using the FlowJo software (Tree Star).
TUNEL assay
The pancreatic cells or tissue were fixed for 30 min in 4% formalde-
hyde, washed for 30 min, and permeabilized in 0.1% Triton X-100 
or 0.1% Na citrate for 2 or 8 min, respectively. The samples were 
washed for 30 min and mixed with 45 l of TUNEL mix and 5 l of 
enzyme per reaction for 1 hour at 37°C in the dark. Then, they were 
washed with PBS and counterstained for 10 min with DAPI. For 
positive control, PPCs were treated for 10 min with 2 U of micrococcal 
nuclease (MNase)/0.01 U of deoxyribonuclease (DNase) I. As a 
negative control, the cells were stained only with the labeling solution.
Telomere length measurement
The measurements of telomere length in pancreata were conducted 
as described previously (60). The pancreata were lysed, and nuclei 
were processed for DNA extraction. After phenol purification, the 
DNA was precipitated with 2.5 volumes of ice-cold 100% EtOH and 
200 mM NaCl at −20°C overnight. DNA quantity was measured 
with nanodrop and diluted at a final concentration of 35 ng/l. The 
PCR program for the telomeric amplification is as follows: 95°C for 10 
min, (95°C for 15 s, 54°C for 2 min, and 72°C for 7 min) × 22 cycles, 
and 72°C for 7 min; and for the single-copy gene (Rarb): 95°C for 10 min, 
(95°C for 15 s, 58°C for 1 min, and 72°C for 30 s) × 30 cycles, 72°C 
for 5 min, and 10°C for forever. For the master mix, 15 mM tris-Cl 
(pH 8), 50 mM KCl, 2 mM MgCl2, 0.2 mM dNTPs (deoxyribonucleotide 
triphosphate), 5 mM dithiothreitol, 1% DMSO, 5× Sybr Green, 
and 1.25 U of Platinum Taq. The standard curve was prepared with the 
use of serial dilutions of a DNA sample of known quantity. The 
primer sequences used in qPCR are, for TelC-telG, GGTTTTTGAGG-
GTGAGGGTGAG (forward) and GGTGAGGGTGAGGGTTC-
CCGACTATCCCTATCCCTATCCCTATCCCTATCCCTA 
(reverse) and, for Rarb, CCTGAGTCAGCAAGGACACT (forward) 
and CCTGAGTCAGCAAGGACACT (reverse).
Immunofluorescence in situ hybridization
PPCs were seeded on coverslips and fixed in 4% PFA/1× PBS for 
10 min at 4°C. Immunostaining for 53BP1 was performed as de-
scribed above; cells were then washed with 1× PBS and fixed again 
in 4% FA/1× PBS for 10 min at RT. After dehydration of the cells in 
increasing concentration of ethanol, 250 nM peanut agglutinin 
telomeric probe (TelC-Cy3; F1002) was added to the coverslip, in 
hybridization buffer [20 mM tris (pH 7.4), 70% formamide, salmon 
sperm DNA (0.1 g/ml), and 2× standard saline citrate (SSC)]. The 
cells were denatured at 85°C for 10 min and then left at RT for 
2 hours. Then, cells were washed in prewarmed 2× SSC/0.1% Tween 20, 
and nuclei were counterstained with DAPI.
Metaphase chromosome spreads
For the metaphase chromosome studies in wt and Er1−/− pancreatic 
cells, cells were arrested in colcemid (0.1 g/ml) for 20 hours, har-
vested by trypsinization, incubated for 15 min at 37°C in 75 mM KCl, 
and fixed in freshly made methanol/acetic acid (3:1). Cells were dropped 
onto wet slides and air-dried overnight in a chemical hood. Fluores-
cence in situ hybridization was performed as described above.
RNA-seq and qPCR
Total RNA was isolated from wt and Er1−/− pancreata with the total 
RNA isolation kit (Qiagen) as described by the manufacturer. For 
RNA-seq, libraries were prepared using an Illumina TruSeq mRNA 
stranded sample preparation kit. Library preparation started with 
1 g of total RNA. After poly-A selection (using poly-T oligo-attached 
magnetic beads), mRNA was purified and fragmented using divalent 
cations under elevated temperature. The RNA fragments under-
went reverse transcription using random primers. This is followed 
by second-strand cDNA synthesis with DNA polymerase I and 
RNase H. After end repair and A-tailing, indexing adapters were 
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cycles) to create the final cDNA libraries. After library validation 
and quantification (Agilent 2100 Bioanalyzer), equimolar amounts 
of library were pooled. The pool was quantified by using the Peqlab 
KAPA Library Quantification Kit and the Applied Biosystems 
7900HT Sequence Detection System. The pool was sequenced by using 
an S2 flow cell on the Illumina NovaSeq6000 sequencer and the 
2x100nt protocol. qPCR was performed with a Bio-Rad 1000-series 
thermal cycler according to the instructions of the manufacturer 
(Bio-Rad) as previously described (61). In case of the qPCR for the 
intronless Ifna gene, the RNA samples were treated with DNase 
(Promega). The generation of specific PCR products was confirmed 
by melting curve analysis and gel electrophoresis. Each primer pair 
was tested with a logarithmic dilution of a cDNA mix to generate a 
linear standard curve [crossing point (CP) plotted versus log of tem-
plate concentration], which was used to calculate the primer pair 
efficiency (E = 10(−1/slope)). Hypoxanthine guanine phosphoribosyl-
transferase 1 (Hprt-1) mRNA was used as an external standard. For 
data analysis, the second derivative maximum method was applied: 
(E1gene of interest CP (cDNA of wt mice − cDNA of Ercc1−/−) gene of interest)/ 
(EGapdh CP (cDNA wt mice − cDNA) gapdh). For cytoplasmic ssDNA qPCR, 
the Klenow fragment of DNA polymerase I was used to generate 
the second strand at 25°C for 1.5 hours in the presence of random 
hexamers and dNTPs.
The genes tested by qPCR are as follows: Il6 (forward: AGTTG-
CCTTCTTGGGACTGA; reverse: CAGAATTGCCATTGCACAAC), 
Ccl2 (forward: TGATCCCAATGAGTAGGCTGGAG; reverse: 
ATGTCTGGACCCATTCCTTCTTG), Cxcl10 (forward: ATGAC-
GGGCCAGTGAGAATG; reverse: CATCGTGGCAATGATCT-
CAACA), Col1 (forward: CCTCAGGGTATTGCTGGACA; reverse: 
TCACGTCCAGATTCACCAGG), Mmp9 (forward: GTCATTCG-
CGTGGATAAGGAG; reverse: CACTGCAGGAGGTCGTAGG), 
Timp2 (forward: CGAGTTTATCTACACGGCCC; reverse: CAG-
GCTCTTCTTCTGGGTGA), Bcl2 (foward: TCGCAGAGATGTC-
CAGTCAG; reverse: ATGCCGGTTCAGGTACTCAG), Casp8 
(forward: GGCCTCCATCTATGACCTGA; reverse: TGTG-
GTTCTGTTGCTCGAAG), Bad (forward: CGTGAGCTC-
CGAAGGATGAG; reverse: TCGCATCTGTGTTGCAGTG), 
Bcl_xl (forward: AGGGGCTTAGCTGCTGAAAG; reverse: GTG-
GACAAGGATCTTGGGGG), P21 (forward: TTGCACTCTGGT-
GTCTGAGC; reverse: TCTGCGCTTGGAGTGATAGA), Sting 
(forward: AAATAACTGCCGCCTCATTG; reverse: TGGGA-
GAGGCTGATCCATAC), Ifit1 (forward: CCAAGTGTTCCAAT-
GCTCCT; reverse: GGATGGAATTGCCTGCTAGA), Ifit2 (foward: 
AGTACAACGAGTAAGGAGTCACT; reverse: AGGCCAGTAT-
GTTGCACATGG), Ifi206 (forward: ACTGTGAGCCTGGGGA-
TAAG; reverse: AGGGATCCATGAGAGTGAGC), II1r1 (forward: 
ACTGTTGCCTGAGGTCTTGG; reverse: CAGCTGAAGCCTC-
CCATATC), Ifn (forward: CTGCTGGCTGTGAGGACATA; reverse: 
GGCTCTCCAGACTTCTGCTC), Ifitm1 (forward: GACAGC-
CACCACAATCAACAT; reverse: CCCAGGCAGCAGAAGTTCAT), 
Usp18 (forward: GAACTCTTTGCCGTGATTGC; reverse: CCAA-
GAGATAGGCCGTTTCC), Mx1 (forward: GACCATAGGG-
GTCTTGACCAA; reverse: AGACTTGCTCTTTCTGAAAAGCC), 
Isg15 (forward: GGTGTCCGTGACTAACTCCAT; reverse: TG-
GAAAGGGTAAGACCGTCCT), Irf8 (forward: CCAAACTCAT-
TCTGGTGCAG; reverse: AAAGGGTCTCTGGTGTGAGG), Irf1 
(forward: GGAAGGGAAGATAGCCGAAG; reverse: GGGCTGT-
CAATCTCTGGTTC), Tnf (forward: CACGTCGTAGCAAAC-
CACC; reverse: GATAGCAAATCGGCTGACGG), Gapdh (forward: 
ACTGAGCAAGAGAGGCCCTA; reverse: TATGGGGGTCTGG-
GATGGAA), Il1 (forward: GCCCATCCTCTGTGACTCAT; reverse: 
TTGTCGTTGCTTGGTTCTCC), Tert (forward: TCAAGCTG-
GCTGCTCATTCT; reverse: GGATGGTCATTGTCGCCTCT), Rarb 
(forward: GGATTAGAGTTTTTGTGTGTTG; reverse: TACCCCAC-
CAATACCCAAACA), Stra6 (forward: ATATGGTGGCGCTCGTAGTG; 
reverse: TCTGCAATGGTCCTGACACC), -actin_pr (forward: GAG-
GGGAGAGGGGGTAAA; reverse: GAAGCTGTGCTCGCGG), 
Β-actin (forward: TAGGGTCGCGGTGTG; reverse: GGTTCCCAA-
TACTGTGTACTC), L1 ORF1 (forward: ATCTGTCTCCCAGGTCT-
GCT; reverse: AGTGCTGCGTTCTGATGATG), L1 ORF2 (forward: 
GCTTCGGTGAAGTAGCTGGA; reverse: TTCGTTAGAGTCAC-
GCCGAG), L1 5′UTR (forward: CTGCCTTGCAAGAAGAGAGC; 




For RNA-seq, the data were downloaded as FASTQ files, and their 
quality was checked with FASTQC, a quality control tool for high- 
throughput sequence data: www.bioinformatics.babraham.ac.uk/
projects/fastqc. A warning for overrepresenting sequences related to 
hydrolytic enzymes was ignored because of the physiology of the 
pancreas. The data were aligned to mm10 genome assembly available 
from the University of California Santa Cruz via Bowtie2. The 
differentially expressed genes were identified with metaseqR. Count 
normalization was performed on the basis of edgeR algorithm. Statisti-
cal analysis was performed with DESeq2, edgeR, and NOISeq algo-
rithms. Differentially expressed genes found by all three algorithms 
were used for downstream analysis. Significant overrepresentation 
of pathways and gene networks was determined by Gene Ontology 
(http://geneontology.org/) and Kyoto Encyclopedia of Genes and 
Genomes pathways (www.genome.jp/kegg/pathway.html). Data 
analysis was performed with the PANTHER Classification System 
using the overrepresentation test. The P values were determined by 
the Fisher’s exact test, and fold enrichment refers to the observed 
over the expected number within the reference list (Mus musculus) 
that map to the annotation data category. For all analyses, unless 
otherwise indicated, P values were calculated by two-tailed Student’s 
t test, and the significance is set at P value ≤ 0.05.
DRIP assay
DRIP analysis was based on the protocol by Goulielmaki et al. (33). 
Briefly, DRIP was performed without a cross-linking step. Nuclei 
were isolated using 0.5% NP-40 buffer and resuspended in TE buffer 
supplemented with 0.5% SDS and 100 mg of proteinase K. Genomic 
DNA was isolated after the addition of potassium acetate (1 M) and 
isopropanol precipitation. DNA was sonicated on ice for 3 min using 
the Covaris S220 Focused Ultrasonicator. Samples were then treated 
with RNase H (10 U/5 g of DNA) at 37°C overnight. Samples 
were immunoprecipitated with S9.6 antibody (8 g of antibody/5 g 
of DNA) overnight at 4°C, followed by incubation for 3 hours with 
protein G–Sepharose beads (Millipore) and washed sequentially. 
The complexes were eluted and resolved on 8 to 12% SDS-PAGE.
ssDNA immunoprecipitation assay
For coimmunoprecipitation assays, untreated or MMC-treated PPCs 
from wt mice or pancreata from wt and Er1−/− mice were fixed in 
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NP-40 lysis buffer [10 mM tris-HCl (pH 7.9), 10 mM NaCl, 3 mM 
MgCl2, 0.5% NP-40, and protease inhibitors]. Cytoplasmic lysates 
(1.5 to 3 mg) were diluted threefold by adding ice-cold HENG buffer 
[10 mM Hepes-KOH (pH 7.9), 1.5 mM MgCl2, 0.25 mM EDTA, 
and 20% glycerol] and precipitated with 5 to 10 g of anti-ssDNA 
antibody (MAB3299) o/n at 4°C followed by incubation for 3 hours 
with protein G Sepharose beads (Millipore). Immunoprecipitates were 
washed five times [10 mM Hepes-KOH (pH 7.9), 300 mM KCl, 
0.3% NP-40, 1.5 mM MgCl2, 0.25 mM EDTA, 20% glycerol, and 
protease inhibitors], eluted, and resolved on 8 to 12% SDS-PAGE.
SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at https://science.org/doi/10.1126/
sciadv.abj5769
View/request a protocol for this paper from Bio-protocol.
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